The state of persistent hyperglycemia in Long COVID-19
Conditions
Interventions
Observation group :nothing
control group:nothing
Sponsors
Chinese Academy of Sciences Traditional Chinese Medicine Resources Center
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-85 years; (2) Fulfills the diagnosis of neocoronavirus infection; (3) No abnormalities in blood glucose before diagnosis of neocoronavirus; (4) Patients agreed to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Abnormal blood glucose or diagnosed diabetes mellitus prior to diagnosis of new coronavirus infection; (2) Pregnant women and breastfeeding women; (3) Persons with a history or family history of convulsions epilepsy encephalopathy or psychiatric disorders; persons with uncontrolled epilepsy and other progressive neurologic disorders; (4) Those who have been diagnosed with congenital or acquired immunodeficiency HIV infection lymphoma leukemia or other autoimmune disease; (5) Are taking or have taken within the month prior to enrollment medications that may affect immune function such as immunosuppressants or immune enhancers or glucocorticoids (=10 mg prednisone or other equivalent glucocorticoids); (6) Participation in other clinical trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete blood count;fasting insulin;2-hour postprandial insulin;glycosylated Hemoglobin;liver and kidney function;fasting C-peptide;2-hour postprandial C-peptide;2-hour postprandial plasma glucose;fasting plasma glucose;virus nucleic acid detection; | — |
Countries
China
Contacts
Public ContactCHEN Wei
The First Affiliated Hospital of Anhui University of Chinese Medicine
Outcome results
None listed